-
October 21, 2026
Wachtell Lipton Rosen & Katz guided healthcare company Abbott in a plan to spin off its nutrition business into an independent, publicly traded company anchored by brands such as adult supplement Ensure and infant formula Similac.
-
October 21, 2026
An SEIU organizer was subjected to intense scrutiny and ultimately fired for taking time off to fulfill her obligations as a member of the U.S. Army Reserve, according to a new lawsuit filed in Pennsylvania federal court.
-
October 21, 2026
The U.S. Supreme Court on Wednesday allowed federal prisons to continue to offer gender transition medical services to incarcerated people.
-
October 20, 2026
The U.S. Department of Justice on Tuesday announced the creation of a whistleblower incentive program offering up-front monetary awards for tips that lead to criminal fraud charges.
-
October 20, 2026
Open-source AI analytics company Metabase Inc. and pediatric telehealth provider Blueberry Medical failed to protect patients' personal health information from being exposed during a cybersecurity attack, and waited several weeks to notify affected individuals, alleges a proposed negligence class action filed Monday in California federal court.
-
October 20, 2026
A New York federal judge has dismissed a proposed shareholder class action alleging medical device maker Integer Holdings Corp. hid plummeting demand for cardiac devices and misled investors about its overall growth, concluding that the allegations do not suggest its disclosures in 2024 and 2025 were untrue or deceptive.
-
October 20, 2026
Meta Platforms Inc. has agreed to have an independent special master rereview potentially thousands of documents the company withheld as privileged in social media addiction multidistrict litigation, after a California federal judge criticized Meta's privilege claims and refused to let Meta use an AI tool to rereview 170,000 documents at issue.
-
October 20, 2026
Two women with diabetes on Monday accused Medtronic of knowingly selling insulin pumps with a known defect that can deliver the wrong amount of insulin that were recalled by the U.S. Food and Drug Administration in 2020.
-
October 20, 2026
The Eleventh Circuit on Tuesday declined to revive a Title VII religious discrimination suit by a former 3M healthcare business division employee who was terminated after refusing to get vaccinated against COVID-19 because of her beliefs, finding that her own statements show that there's no conflict between her beliefs and 3M's policy.
-
October 20, 2026
A Michigan pharmacist serving an eight-year prison sentence for medical fraud is entitled to a new trial, his attorney told a Sixth Circuit panel Tuesday, arguing that a key defense witness in the case was threatened by the government and dissuaded from testifying.
-
October 20, 2026
A Second Circuit panel affirmed a lower court's decision Tuesday, refusing to block Connecticut from enforcing a cap on generic and off-patent drug prices while a trade association for drug wholesalers challenges the statute.
-
October 20, 2026
Comcast has asked a Pennsylvania federal judge to dismiss a proposed class action accusing it of violating federal benefits law by imposing a surcharge for tobacco use, saying its health and welfare benefit plan is "more generous" than required.
-
October 20, 2026
A real estate investment trust sued a Boston suburb Tuesday, blaming drug activity near its 146-unit apartment building on a public health initiative to provide a vending machine nearby for the overdose treatment Narcan.
-
October 20, 2026
The Seventh Circuit on Tuesday joined a host of other appellate courts in determining healthcare providers were not "acting under" the federal government when they created patient web portals, finding actions alleging hospitals improperly shared patient information belonged in state court.
-
October 20, 2026
An Illinois laboratory executive has been charged with orchestrating a $66 million COVID-19 testing fraud scheme, allegedly fabricating negative results and billing a federal program for approximately 380,000 tests that were never performed.
-
October 20, 2026
An insurer said it owes no coverage to a Washington state OB-GYN accused of advising a patient to terminate a normal pregnancy based on a misdiagnosis, telling a federal court that the patient's request for medical records before the policy took effect triggers a coverage exclusion.
-
October 20, 2026
Law firm Polsinelli PC has asked a Tennessee federal judge to sanction a medical device company for advancing what it says were "knowingly false and materially incomplete" positions in a suit accusing the firm of pursuing bad faith patent infringement claims on behalf of a client.
-
October 20, 2026
The city of Los Angeles is urging the Ninth Circuit to throw out a challenge to its social equity cannabis licensure program, saying the Constitution's dormant commerce clause doesn't apply to marijuana regardless of recent changes to federal cannabis policy.
-
October 20, 2026
Britain's antitrust regulator invited comments Tuesday on whether local medical device maker Intersurgical's proposed $530 million acquisition of two businesses could harm competition in U.K. markets.
-
October 20, 2026
Freshfields LLP has hired a former Gibson Dunn & Crutcher LLP lawyer who focuses his practice on identifying, assessing and mitigating risks associated with U.S. Food and Drug Administration oversight, the firm recently announced.
-
October 19, 2026
A California federal judge has certified a class of roughly 95,500 California contact lens purchasers who subscribed to Hubble Contacts, an online service accused of deceiving its customers by secretly substituting every customer order with its own Hubble-brand lenses.
-
October 19, 2026
A dozen states reported collecting a total of $240.5 million in fees during the 2025 calendar year to support a federal suicide hotline while seven tribal authorities said they lack a funding mechanism to do so, according to a Federal Communications Commission report.
-
October 19, 2026
California and 23andMe's corporate successor have reached a $6 million settlement that, if approved, would resolve the state's allegations that the genetic testing company failed to protect customers' sensitive information in a 2023 data breach, as well as the state's objection to 23andMe's sale of genetic data during bankruptcy proceedings.
-
October 19, 2026
Biotechnology company TriGemX Bio on Monday unveiled plans to go public by merging with special purpose acquisition company TCGX Acquisition Corp. in a deal built by five law firms that creates a combined company with a $600 million post-transaction equity value.
-
October 19, 2026
The Port of Seattle and several Washington cities and counties asked a federal judge to block the Trump administration from enforcing new grant conditions that would threaten $87 million in funding, arguing the restrictions lack clear standards of conduct.